These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 12671541)
1. Mammographic densities in a one-year isoflavone intervention. Maskarinec G; Williams AE; Carlin L Eur J Cancer Prev; 2003 Apr; 12(2):165-9. PubMed ID: 12671541 [TBL] [Abstract][Full Text] [Related]
2. Various doses of soy isoflavones do not modify mammographic density in postmenopausal women. Maskarinec G; Verheus M; Steinberg FM; Amato P; Cramer MK; Lewis RD; Murray MJ; Young RL; Wong WW J Nutr; 2009 May; 139(5):981-6. PubMed ID: 19321587 [TBL] [Abstract][Full Text] [Related]
3. Double-Blind Randomized 12-Month Soy Intervention Had No Effects on Breast MRI Fibroglandular Tissue Density or Mammographic Density. Wu AH; Spicer D; Garcia A; Tseng CC; Hovanessian-Larsen L; Sheth P; Martin SE; Hawes D; Russell C; MacDonald H; Tripathy D; Su MY; Ursin G; Pike MC Cancer Prev Res (Phila); 2015 Oct; 8(10):942-51. PubMed ID: 26276750 [TBL] [Abstract][Full Text] [Related]
4. Soy protein containing isoflavones and mammographic density in a randomized controlled trial in postmenopausal women. Verheus M; van Gils CH; Kreijkamp-Kaspers S; Kok L; Peeters PH; Grobbee DE; van der Schouw YT Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2632-8. PubMed ID: 18843004 [TBL] [Abstract][Full Text] [Related]
5. Effects of soy isoflavones on mammographic density and breast parenchyma in postmenopausal women: a randomized, double-blind, placebo-controlled clinical trial. Delmanto A; Nahas-Neto J; Traiman P; Uemura G; Pessoa EC; Nahas EA Menopause; 2013 Oct; 20(10):1049-54. PubMed ID: 23481125 [TBL] [Abstract][Full Text] [Related]
6. Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]. Atkinson C; Warren RM; Sala E; Dowsett M; Dunning AM; Healey CS; Runswick S; Day NE; Bingham SA Breast Cancer Res; 2004; 6(3):R170-9. PubMed ID: 15084240 [TBL] [Abstract][Full Text] [Related]
7. Epidemiologic studies of isoflavones & mammographic density. Maskarinec G; Verheus M; Tice JA Nutrients; 2010 Jan; 2(1):35-48. PubMed ID: 22253990 [TBL] [Abstract][Full Text] [Related]
8. A 2-year soy intervention in premenopausal women does not change mammographic densities. Maskarinec G; Takata Y; Franke AA; Williams AE; Murphy SP J Nutr; 2004 Nov; 134(11):3089-94. PubMed ID: 15514280 [TBL] [Abstract][Full Text] [Related]
9. Red clover isoflavones are safe and well tolerated in women with a family history of breast cancer. Powles TJ; Howell A; Evans DG; McCloskey EV; Ashley S; Greenhalgh R; Affen J; Flook LA; Tidy A Menopause Int; 2008 Mar; 14(1):6-12. PubMed ID: 18380954 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study. Nahas EA; Nahas-Neto J; Orsatti FL; Carvalho EP; Oliveira ML; Dias R Maturitas; 2007 Nov; 58(3):249-58. PubMed ID: 17913408 [TBL] [Abstract][Full Text] [Related]
11. Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial. Levis S; Strickman-Stein N; Ganjei-Azar P; Xu P; Doerge DR; Krischer J Arch Intern Med; 2011 Aug; 171(15):1363-9. PubMed ID: 21824950 [TBL] [Abstract][Full Text] [Related]
12. Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women. Frankenfeld CL; McTiernan A; Aiello EJ; Thomas WK; LaCroix K; Schramm J; Schwartz SM; Holt VL; Lampe JW Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1156-62. PubMed ID: 15247126 [TBL] [Abstract][Full Text] [Related]
13. Dietary phytoestrogen intake and mammographic density -- results of a pilot study. Nagel G; Mack U; von Fournier D; Linseisen J Eur J Med Res; 2005 Sep; 10(9):389-94. PubMed ID: 16183551 [TBL] [Abstract][Full Text] [Related]
14. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. Spicer DV; Ursin G; Parisky YR; Pearce JG; Shoupe D; Pike A; Pike MC J Natl Cancer Inst; 1994 Mar; 86(6):431-6. PubMed ID: 8120917 [TBL] [Abstract][Full Text] [Related]
15. Soy isoflavones: no effects on bone mineral content and bone mineral density in healthy, menstruating young adult women after one year. Anderson JJ; Chen X; Boass A; Symons M; Kohlmeier M; Renner JB; Garner SC J Am Coll Nutr; 2002 Oct; 21(5):388-93. PubMed ID: 12356779 [TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women. Liu ZM; Ho SC; Woo J; Chen YM; Wong C Menopause; 2014 Jun; 21(6):653-60. PubMed ID: 24149925 [TBL] [Abstract][Full Text] [Related]
17. Effect of a soy isoflavone supplement on lung function and clinical outcomes in patients with poorly controlled asthma: a randomized clinical trial. Smith LJ; Kalhan R; Wise RA; Sugar EA; Lima JJ; Irvin CG; Dozor AJ; Holbrook JT; JAMA; 2015 May; 313(20):2033-43. PubMed ID: 26010632 [TBL] [Abstract][Full Text] [Related]
18. A randomized isoflavone intervention among premenopausal women. Maskarinec G; Williams AE; Inouye JS; Stanczyk FZ; Franke AA Cancer Epidemiol Biomarkers Prev; 2002 Feb; 11(2):195-201. PubMed ID: 11867507 [TBL] [Abstract][Full Text] [Related]
19. Legumes and soybeans: overview of their nutritional profiles and health effects. Messina MJ Am J Clin Nutr; 1999 Sep; 70(3 Suppl):439S-450S. PubMed ID: 10479216 [TBL] [Abstract][Full Text] [Related]
20. Mammographic breast density as a biomarker of effects of isoflavones on the female breast. Atkinson C; Bingham SA Breast Cancer Res; 2002; 4(1):1-4. PubMed ID: 11879551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]